Mortality prediction using CHADS2 /CHA2 DS2 -VASc/R2 CHADS2 scores in systolic heart failure patients with or without atrial fibrillation

Yung Lung Chen, Ching Lan Cheng, Jin Long Huang, Ning I. Yang, Heng Chia Chang, Kuan Cheng Chang, Shih Hsien Sung, Kou Gi Shyu, Chun Chieh Wang, Wei Hsian Yin, Jiunn Lee Lin, Shyh Ming Chen

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The CHADS2, CHA2 DS2 -VASc, and R2 CHADS 2 scores are well-known predictors of stroke caused by atrial fibrillation (AF), but no studies have evaluated their use for stratifying all-cause mortality risk in patients discharged for systolic heart failure (SHF) with or without AF. This study analyzed data in the Taiwan Society of Cardiology - heart failure with reduced ejection fraction (TSOC-HFrEF) registry. These data were obtained by a prospective, multicenter, observational survey of patients treated at 21 medical centers in Taiwan after hospitalization for acute, pre-existing or new onset SHF from May, 2013 to October, 2014. During 1 year follow-up, 198 patients were lost follow-up, and final 1311 (86.8%) patients were included for further analysis. During the follow-up period, 250 (19%) patients died. Multivariate analysis revealed that body mass index, thyroid disorder, valvular surgery history, chronic kidney disease (CKD), and scores for CHADS2, CHA2 DS2- VASc, and R2 CHADS2 were significant independent predictors of mortality in the overall population of SHF patients (all P<.05) The c-indexes showed that CHADS2, CHA2 DS2 -VASc, and R2 CHADS2 scores were significantly associated with mortality in SHF patients with or without AF (all P<005). However, R2 CHADS2 had significantly higher accuracy in predicting mortality in all SHF patients compared with CHADS2 and CHA2 DS2 -VASc (DeLong test, P<.0001), especially in SHF without AF (DeLong test, P=.0003). Scores for CHADS2, CHA2 DS2 -VASc, and R2 CHADS2 can be used to predict 1-year all-cause mortality in SHF patients with or without AF. For predicting all-cause mortality in SHF patients, R 2 CHADS 2 is more accurate than CHADS2 and CHA2 DS2 -VASc.

Original languageEnglish
Article numbere8338
JournalMedicine (United States)
Volume96
Issue number43
DOIs
Publication statusPublished - Oct 1 2017
Externally publishedYes

Fingerprint

Systolic Heart Failure
Atrial Fibrillation
Mortality
Taiwan
Cardiology
Chronic Renal Insufficiency
Registries
Thyroid Gland
Hospitalization
Body Mass Index
Multivariate Analysis
Heart Failure
History
Stroke

Keywords

  • atrial fibrillation
  • mortality
  • risk score
  • systolic heart failure

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mortality prediction using CHADS2 /CHA2 DS2 -VASc/R2 CHADS2 scores in systolic heart failure patients with or without atrial fibrillation. / Chen, Yung Lung; Cheng, Ching Lan; Huang, Jin Long; Yang, Ning I.; Chang, Heng Chia; Chang, Kuan Cheng; Sung, Shih Hsien; Shyu, Kou Gi; Wang, Chun Chieh; Yin, Wei Hsian; Lin, Jiunn Lee; Chen, Shyh Ming.

In: Medicine (United States), Vol. 96, No. 43, e8338, 01.10.2017.

Research output: Contribution to journalArticle

Chen, YL, Cheng, CL, Huang, JL, Yang, NI, Chang, HC, Chang, KC, Sung, SH, Shyu, KG, Wang, CC, Yin, WH, Lin, JL & Chen, SM 2017, 'Mortality prediction using CHADS2 /CHA2 DS2 -VASc/R2 CHADS2 scores in systolic heart failure patients with or without atrial fibrillation', Medicine (United States), vol. 96, no. 43, e8338. https://doi.org/10.1097/MD.0000000000008338
Chen, Yung Lung ; Cheng, Ching Lan ; Huang, Jin Long ; Yang, Ning I. ; Chang, Heng Chia ; Chang, Kuan Cheng ; Sung, Shih Hsien ; Shyu, Kou Gi ; Wang, Chun Chieh ; Yin, Wei Hsian ; Lin, Jiunn Lee ; Chen, Shyh Ming. / Mortality prediction using CHADS2 /CHA2 DS2 -VASc/R2 CHADS2 scores in systolic heart failure patients with or without atrial fibrillation. In: Medicine (United States). 2017 ; Vol. 96, No. 43.
@article{df4fbccc37e24b64a829568136cf3eba,
title = "Mortality prediction using CHADS2 /CHA2 DS2 -VASc/R2 CHADS2 scores in systolic heart failure patients with or without atrial fibrillation",
abstract = "The CHADS2, CHA2 DS2 -VASc, and R2 CHADS 2 scores are well-known predictors of stroke caused by atrial fibrillation (AF), but no studies have evaluated their use for stratifying all-cause mortality risk in patients discharged for systolic heart failure (SHF) with or without AF. This study analyzed data in the Taiwan Society of Cardiology - heart failure with reduced ejection fraction (TSOC-HFrEF) registry. These data were obtained by a prospective, multicenter, observational survey of patients treated at 21 medical centers in Taiwan after hospitalization for acute, pre-existing or new onset SHF from May, 2013 to October, 2014. During 1 year follow-up, 198 patients were lost follow-up, and final 1311 (86.8{\%}) patients were included for further analysis. During the follow-up period, 250 (19{\%}) patients died. Multivariate analysis revealed that body mass index, thyroid disorder, valvular surgery history, chronic kidney disease (CKD), and scores for CHADS2, CHA2 DS2- VASc, and R2 CHADS2 were significant independent predictors of mortality in the overall population of SHF patients (all P<.05) The c-indexes showed that CHADS2, CHA2 DS2 -VASc, and R2 CHADS2 scores were significantly associated with mortality in SHF patients with or without AF (all P<005). However, R2 CHADS2 had significantly higher accuracy in predicting mortality in all SHF patients compared with CHADS2 and CHA2 DS2 -VASc (DeLong test, P<.0001), especially in SHF without AF (DeLong test, P=.0003). Scores for CHADS2, CHA2 DS2 -VASc, and R2 CHADS2 can be used to predict 1-year all-cause mortality in SHF patients with or without AF. For predicting all-cause mortality in SHF patients, R 2 CHADS 2 is more accurate than CHADS2 and CHA2 DS2 -VASc.",
keywords = "atrial fibrillation, mortality, risk score, systolic heart failure",
author = "Chen, {Yung Lung} and Cheng, {Ching Lan} and Huang, {Jin Long} and Yang, {Ning I.} and Chang, {Heng Chia} and Chang, {Kuan Cheng} and Sung, {Shih Hsien} and Shyu, {Kou Gi} and Wang, {Chun Chieh} and Yin, {Wei Hsian} and Lin, {Jiunn Lee} and Chen, {Shyh Ming}",
year = "2017",
month = "10",
day = "1",
doi = "10.1097/MD.0000000000008338",
language = "English",
volume = "96",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "43",

}

TY - JOUR

T1 - Mortality prediction using CHADS2 /CHA2 DS2 -VASc/R2 CHADS2 scores in systolic heart failure patients with or without atrial fibrillation

AU - Chen, Yung Lung

AU - Cheng, Ching Lan

AU - Huang, Jin Long

AU - Yang, Ning I.

AU - Chang, Heng Chia

AU - Chang, Kuan Cheng

AU - Sung, Shih Hsien

AU - Shyu, Kou Gi

AU - Wang, Chun Chieh

AU - Yin, Wei Hsian

AU - Lin, Jiunn Lee

AU - Chen, Shyh Ming

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The CHADS2, CHA2 DS2 -VASc, and R2 CHADS 2 scores are well-known predictors of stroke caused by atrial fibrillation (AF), but no studies have evaluated their use for stratifying all-cause mortality risk in patients discharged for systolic heart failure (SHF) with or without AF. This study analyzed data in the Taiwan Society of Cardiology - heart failure with reduced ejection fraction (TSOC-HFrEF) registry. These data were obtained by a prospective, multicenter, observational survey of patients treated at 21 medical centers in Taiwan after hospitalization for acute, pre-existing or new onset SHF from May, 2013 to October, 2014. During 1 year follow-up, 198 patients were lost follow-up, and final 1311 (86.8%) patients were included for further analysis. During the follow-up period, 250 (19%) patients died. Multivariate analysis revealed that body mass index, thyroid disorder, valvular surgery history, chronic kidney disease (CKD), and scores for CHADS2, CHA2 DS2- VASc, and R2 CHADS2 were significant independent predictors of mortality in the overall population of SHF patients (all P<.05) The c-indexes showed that CHADS2, CHA2 DS2 -VASc, and R2 CHADS2 scores were significantly associated with mortality in SHF patients with or without AF (all P<005). However, R2 CHADS2 had significantly higher accuracy in predicting mortality in all SHF patients compared with CHADS2 and CHA2 DS2 -VASc (DeLong test, P<.0001), especially in SHF without AF (DeLong test, P=.0003). Scores for CHADS2, CHA2 DS2 -VASc, and R2 CHADS2 can be used to predict 1-year all-cause mortality in SHF patients with or without AF. For predicting all-cause mortality in SHF patients, R 2 CHADS 2 is more accurate than CHADS2 and CHA2 DS2 -VASc.

AB - The CHADS2, CHA2 DS2 -VASc, and R2 CHADS 2 scores are well-known predictors of stroke caused by atrial fibrillation (AF), but no studies have evaluated their use for stratifying all-cause mortality risk in patients discharged for systolic heart failure (SHF) with or without AF. This study analyzed data in the Taiwan Society of Cardiology - heart failure with reduced ejection fraction (TSOC-HFrEF) registry. These data were obtained by a prospective, multicenter, observational survey of patients treated at 21 medical centers in Taiwan after hospitalization for acute, pre-existing or new onset SHF from May, 2013 to October, 2014. During 1 year follow-up, 198 patients were lost follow-up, and final 1311 (86.8%) patients were included for further analysis. During the follow-up period, 250 (19%) patients died. Multivariate analysis revealed that body mass index, thyroid disorder, valvular surgery history, chronic kidney disease (CKD), and scores for CHADS2, CHA2 DS2- VASc, and R2 CHADS2 were significant independent predictors of mortality in the overall population of SHF patients (all P<.05) The c-indexes showed that CHADS2, CHA2 DS2 -VASc, and R2 CHADS2 scores were significantly associated with mortality in SHF patients with or without AF (all P<005). However, R2 CHADS2 had significantly higher accuracy in predicting mortality in all SHF patients compared with CHADS2 and CHA2 DS2 -VASc (DeLong test, P<.0001), especially in SHF without AF (DeLong test, P=.0003). Scores for CHADS2, CHA2 DS2 -VASc, and R2 CHADS2 can be used to predict 1-year all-cause mortality in SHF patients with or without AF. For predicting all-cause mortality in SHF patients, R 2 CHADS 2 is more accurate than CHADS2 and CHA2 DS2 -VASc.

KW - atrial fibrillation

KW - mortality

KW - risk score

KW - systolic heart failure

UR - http://www.scopus.com/inward/record.url?scp=85032615429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032615429&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000008338

DO - 10.1097/MD.0000000000008338

M3 - Article

C2 - 29069008

AN - SCOPUS:85032615429

VL - 96

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 43

M1 - e8338

ER -